Last updated: July 5, 2023
Sponsor: National Cancer Institute, Egypt
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anesthesia (Local)
Treatment
peri capsular nerve group block
scaitico femoral block
Clinical Study ID
NCT05819879
AP2102-30101
Ages 20-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ASA class I and II
- Age above 20 and less than 60 years.
- Patients undergoing above knee amputation due to any type of cancer
Exclusion
Exclusion Criteria:
- Patient refusal.
- Local infection at the puncture site.
- Coagulopathy.
- Cognitive disorders.
- Unstable cardiovascular disease.
- History of psychiatric disorders.
- History of drug abuse.
- Patients allergic to medication used.
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: peri capsular nerve group block
Phase:
Study Start date:
June 10, 2023
Estimated Completion Date:
September 20, 2023
Study Description
Connect with a study center
Ahmed Ibrahim Hussien Hussien
Cairo, 11511
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.